Psychedelics potential set to extend beyond mental health
While mental health has previously been the focus of psychedelics research, the drug class is also emerging in neurological ...
Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating
Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS ...
Stockhead
Biocurious: ‘My finest hour and my biggest regret’ – biotech veterans reflect on two decades in the game
At a recent lunch in Melbourne, two dozen luminaries exchanged war stories about their two decades-plus involvement in the ...
Pharmaceutical Technology on MSN
J&J’s Darzalex gains first FDA approval in smouldering multiple myeloma
This approval marks a milestone for high-risk sMM patients, but analyst Biswajit Podder notes that there are caveats to its ...
Adrenaline nasal sprays may work as well as EpiPen for allergic shock
People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as to jab themselves in a ...
J&J’s Caplyta wins MDD approval to extend revenue horizon
Caplyta (lumateperone) has scored a label extension into the depression setting, underscoring the belief Johnson & Johnson (J ...
J&J brain drug acquired in $14.6B buyout cleared for broader use
Caplyta, which J&J got in its acquisition of Intra-Cellular Therapies, netted a clearance in major depressive disorder that’s key to achieving the $5 billion in annualized sales the company expects.
pharmaphorum
J&J adds first new indication for Caplyta since takeover
The US regulator has cleared Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major ...
Fierce Pharma
J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder
Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health ...
Life Sciences’ shareholders voted to approve the strategic combination with Beckley Psytech Limited and the corporate redomiciliation at the ...
Reuters
US FDA approves Bayer's menopause relief drug
Oct 24 (Reuters) - The U.S. Food and Drug Administration has approved Bayer's (BAYGn.DE), opens new tab drug to ease hot flashes in menopausal women, the German company said on Friday, a welcome ...
MedCity News
GSK Blood Cancer Drug Returns to the U.S. Market, But New FDA Approval Is Still Limited
GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...